AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 10%
#501 out of 5057 analysts
Average Return
+11.52%
Win Rate
45%69 out of 153
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phathom Pharmaceuticals IncPHAT | +353.99% | $2.76 | $12.53 | 2025-05-02 - 2025-10-13 | Buy |
Mineralys Therapeutics IncMLYS | +322.06% | $10.20 | $43.05 | 2025-02-13 - 2025-10-13 | Buy |
Zenas Biopharma IncZBIO | +223.26% | $8.21 | $26.54 | 2025-03-12 - 2025-10-13 | Buy |
Mineralys Therapeutics IncMLYS | +221.75% | $13.38 | $43.05 | 2024-11-12 - 2025-10-13 | Buy |
Mineralys Therapeutics IncMLYS | +221.75% | $13.38 | $43.05 | 2024-10-31 - 2025-10-13 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zenas Biopharma IncZBIO | 4 | Buy | $30.00 | +13.04% | Reiterates | 5 days ago |
Immunic IncIMUX | 5 | Buy | $10.00 | +1,017.32% | Reiterates | 18 days ago |
Adverum Biotechnologies IncADVM | 7 | Buy | $30.00 | +621.15% | Reiterates | 21 days ago |
Fibrobiologics IncFBLG | 6 | Buy | $10.00 | +2,183.11% | Reiterates | a month ago |
Mineralys Therapeutics IncMLYS | 11 | Buy | $42.00 | -2.44% | Reiterates | a month ago |
Kodiak Sciences IncKOD | 5 | Hold | $5.00 | -56.90% | Maintains | 2 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +69.97% | Reiterates | 2 months ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +102.02% | Reiterates | 2 months ago |
Lenz Therapeutics IncLENZ | 7 | Buy | $56.00 | +45.04% | Maintains | 2 months ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +300.00% | Reiterates | 4 months ago |
Ardelyx IncARDX | 1 | Buy | $10.00 | +99.60% | Assumes | 4 months ago |
Phathom Pharmaceuticals IncPHAT | 10 | Buy | $20.00 | +59.62% | Reiterates | 4 months ago |
Akebia Therapeutics IncAKBA | 1 | Buy | $8.00 | +187.77% | Assumes | 4 months ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | +900.00% | Downgrades | 5 months ago |
Tarsus Pharmaceuticals IncTARS | 1 | Buy | $72.00 | +2.36% | Assumes | 5 months ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | 5 months ago |
Aldeyra Therapeutics IncALDX | 13 | Buy | $10.00 | +90.48% | Reiterates | 5 months ago |
Surrozen IncSRZN | 3 | Buy | $32.00 | +131.55% | Reiterates | 5 months ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | -4.31% | Reiterates | 6 months ago |
Opthea LtdOPT | 7 | Hold | $2.00 | -41.35% | Downgrades | 7 months ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | -74.29% | Reiterates | 7 months ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | +272.29% | Reiterates | 7 months ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.